Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials

Study Questions:

What is the range in lipoprotein levels achieved with statin therapy and the cardiovascular disease risk reduction associated with very low levels of atherogenic lipoproteins achieved with statin therapy?